Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 0.871M
February 28, 2026 0.061M
November 30, 2025 0.482M
August 31, 2025 0.92M
May 31, 2025 -0.005M
February 28, 2025 1.736M
November 30, 2024 0.38M
August 31, 2024 0.00
May 31, 2024 -0.081M
February 29, 2024 0.00
November 30, 2023 0.00
August 31, 2023 0.00
May 31, 2023 7.350M
February 28, 2023 0.0254M
November 30, 2022 0.2375M
August 31, 2022 1.778M
May 31, 2022 0.0382M
February 28, 2022 0.6377M
November 30, 2021 0.914M
August 31, 2021 0.8046M
May 31, 2021 0.0058M
February 28, 2021 1.059M
November 30, 2020 0.0344M
August 31, 2020 0.0149M
May 31, 2020 9.810M
Date Value
February 29, 2020 2.007M
November 30, 2019 0.41M
August 31, 2019 0.1466M
May 31, 2019 0.8101M
February 28, 2019 0.0854M
November 30, 2018 0.8145M
August 31, 2018 0.1974M
May 31, 2018 0.99M
February 28, 2018 0.2906M
November 30, 2017 0.0128M
August 31, 2017 0.001M
May 31, 2017 0.0187M
February 28, 2017 0.0824M
November 30, 2016 0.0566M
August 31, 2016 0.00
May 31, 2016 1.068M
February 29, 2016 0.028M
November 30, 2015 0.0037M
August 31, 2015 0.0066M
May 31, 2015 0.0052M
February 28, 2015 0.0009M
November 30, 2014 0.0066M
August 31, 2014 -0.0031M
May 31, 2014 0.018M
February 28, 2014 0.1655M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Univec, Inc. 0.0157M
Lantheus Holdings, Inc. 4.505M
Zomedica Corp. 0.00
IDEXX Laboratories, Inc. -325.19M
Neogen Corp. -0.30M